← Back to Patent Explorer
US5360616A Expired / Lapsed US ⏱️ 0.0 years remaining

Injectable pharmaceutical composition

Assignee: Aplicaciones Farmaceuticas SA de CV
•
Filing: 1991-06-13
•
Granted: 1994-11-01
•
Expires: 2011-06-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Formulations of programmed-release medicinal products intended for parenteral administration by injection, comprising calibrated solid microspheres (1 to 300 microns) of active substances. Provided in this form, steroids (for example progesterone and 17- beta -estradiol) may constitute injectable contraceptives, and the action of drugs having an approximatively 24 hours lasting effect may be regulated and extended.

Inventors

  • 👤 Josue Garza Flores
  • 👤 Laura P. Laiseca Soto
  • 👤 Jose Guillen Pichardo
  • 👤 Juan Angeles Uribe

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:29
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/14; A61K9/16; A61K9/1682; A61K9/1694; A61K9/1688; A61P; A61P3/00; A61P3/02; A61P43/00

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 44 words
Solid, non-porous microspheres of a diameter between 1 and 300 μm, wherein said microspheres consist of an injectable steroid and wherein said microspheres are obtained by spraying said steroid in the melted state to form droplets and rapidly freezing said droplets in a gas.
Claim 2
Dependent Claim 44 words
Solid, non-porous microspheres of a diameter between 1 and 300 μm, wherein said microspheres consist of an injectable steroid and wherein said microspheres are obtained by spraying said steroid in the melted state to form droplets and rapidly freezing said droplets in a gas.
Claim 3
Dependent Claim 20 words
The solid, non-porous microspheres according to claim 1, wherein the diameter of said microspheres is between 5 and 100 μm.
Claim 4
Dependent Claim 31 words
The solid, non-porous microspheres according to claim 2, wherein the melting point of said steroid is greater than 60 ° C. and wherein said steroid is thermostable above the melting point.
Claim 5
Dependent Claim 13 words
The solid, non-porous microspheres according to claim 1, wherein said steroid is progesterone.
Claim 6
Dependent Claim 13 words
The solid, non-porous microspheres according to claim 1, wherein said steroid is 17-β-estradiol.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-10-31 1998-05-02 1998-11-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-10-31 2002-05-02 2002-11-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-10-31 2006-05-02 2006-11-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag